{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:27:12Z","timestamp":1787243232091,"version":"build-2736575974"},"reference-count":64,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"DOI":"10.1210\/en.2016-1609","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T14:00:53Z","timestamp":1481205653000},"page":"410-418","source":"Crossref","is-referenced-by-count":33,"title":["CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor \u03baB Activation"],"prefix":"10.1210","volume":"158","author":[{"given":"Hanna J.","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Endocrinology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Stefan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk wun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"William B.","family":"Inabnet","sequence":"additional","affiliation":[{"name":"Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York 10029; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall P.","family":"Owen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York 10029; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlinda","family":"Concepcion","sequence":"additional","affiliation":[{"name":"Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Tomer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,12,8]]},"reference":[{"key":"2019041122041387100_B1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1089\/thy.2007.0153","article-title":"The genetic basis of thyroid autoimmunity","volume":"17","author":"Jacobson","year":"2007","journal-title":"Thyroid"},{"issue":"3","key":"2019041122041387100_B2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40618-014-0214-2","article-title":"Role of genetic and non-genetic factors in the etiology of Graves\u2019 disease","volume":"38","author":"Marin\u00f2","year":"2015","journal-title":"J Endocrinol Invest"},{"issue":"3-4","key":"2019041122041387100_B3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaut.2009.02.007","article-title":"The etiology of autoimmune thyroid disease: a story of genes and environment","volume":"32","author":"Tomer","year":"2009","journal-title":"J Autoimmun"},{"key":"2019041122041387100_B4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1530\/EJE-10-1155","article-title":"Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study","volume":"164","author":"Carle","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2019041122041387100_B5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019041122041387100_B6","first-page":"930","article-title":"Evidence for a major role of heredity in Graves\u2019 disease: a population-based study of two Danish twin cohorts","volume":"86","author":"Brix","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122041387100_B7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-012513-104713","article-title":"Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics","volume":"9","author":"Tomer","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"2019041122041387100_B8","doi-asserted-by":"crossref","first-page":"E144","DOI":"10.1210\/jc.2012-2408","article-title":"Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes","volume":"98","author":"Tomer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041122041387100_B9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1086\/378588","article-title":"Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families","volume":"73","author":"Tomer","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2019041122041387100_B10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.smim.2009.05.008","article-title":"Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis","volume":"21","author":"Munroe","year":"2009","journal-title":"Semin Immunol"},{"issue":"5","key":"2019041122041387100_B11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin Immunol"},{"issue":"10","key":"2019041122041387100_B12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/gut.52.10.1435","article-title":"Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients","volume":"52","author":"Danese","year":"2003","journal-title":"Gut"},{"issue":"2","key":"2019041122041387100_B13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1521-6616(02)00028-1","article-title":"Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis","volume":"106","author":"Filion","year":"2003","journal-title":"Clin Immunol"},{"issue":"4","key":"2019041122041387100_B14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/rheumatology\/kes339","article-title":"Association of genetic polymorphisms in CD40 with susceptibility to SLE in the Korean population","volume":"52","author":"Joo","year":"2013","journal-title":"Rheumatology"},{"issue":"7","key":"2019041122041387100_B15","doi-asserted-by":"crossref","first-page":"e11520","DOI":"10.1371\/journal.pone.0011520","article-title":"CD40: novel association with Crohn\u2019s disease and replication in multiple sclerosis susceptibility [published correction appears in PLoS One 2010:5(8)]","volume":"5","author":"Blanco-Kelly","year":"2010","journal-title":"PLoS One"},{"key":"2019041122041387100_B16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00296-015-3345-7","article-title":"Association of CD40 polymorphisms and haplotype with risk of systemic lupus erythematosus","volume":"36","author":"Wu","year":"2016","journal-title":"Rheumatol Int"},{"key":"2019041122041387100_B17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12031-015-0490-0","article-title":"MS risk allele rs1883832T is associated with decreased mRNA expression of CD40","volume":"56","author":"Wagner","year":"2015","journal-title":"J Mol Neurosci."},{"issue":"10","key":"2019041122041387100_B18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.233","article-title":"Common variants at CD40 and other loci confer risk of rheumatoid arthritis","volume":"40","author":"Raychaudhuri","year":"2008","journal-title":"Nat Genet"},{"issue":"5","key":"2019041122041387100_B19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00296-014-3171-3","article-title":"Associations of rs4810485 and rs1883832 polymorphisms of CD40 gene with susceptibility and clinical findings of Beh\u00e7et\u2019s disease","volume":"35","author":"\u0130nal","year":"2015","journal-title":"Rheumatol Int"},{"issue":"3","key":"2019041122041387100_B20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.gene.6364375","article-title":"A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression","volume":"8","author":"Jacobson","year":"2007","journal-title":"Genes Immun"},{"issue":"6","key":"2019041122041387100_B21","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.4049\/jimmunol.1200311","article-title":"Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease","volume":"189","author":"Huber","year":"2012","journal-title":"J Immunol"},{"key":"2019041122041387100_B22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/105072502321085234","article-title":"A C\/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease","volume":"12","author":"Tomer","year":"2002","journal-title":"Thyroid"},{"issue":"2","key":"2019041122041387100_B23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/clin.1997.4391","article-title":"Coexpression of CD40 and class II antigen HLA-DR in Graves\u2019 disease thyroid epithelial cells","volume":"84","author":"Faure","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"issue":"6-7","key":"2019041122041387100_B24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/08916930400002386","article-title":"The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway","volume":"37","author":"Toubi","year":"2004","journal-title":"Autoimmunity"},{"issue":"7","key":"2019041122041387100_B25","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.4049\/jimmunol.156.7.2345","article-title":"CD40-mediated signaling in B cells: balancing cell survival, growth, and death","volume":"156","author":"Kehry","year":"1996","journal-title":"J Immunol"},{"issue":"10","key":"2019041122041387100_B26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0167-5699(96)10060-I","article-title":"The many roles of CD40 in cell-mediated inflammatory responses","volume":"17","author":"Stout","year":"1996","journal-title":"Immunol Today"},{"issue":"5","key":"2019041122041387100_B27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.smim.2009.08.002","article-title":"The many faces of CD40: multiple roles in normal immunity and disease","volume":"21","author":"Bishop","year":"2009","journal-title":"Semin Immunol"},{"issue":"3-4","key":"2019041122041387100_B28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1359-6101(03)00024-8","article-title":"The CD40-CD154 interaction in B cell-T cell liaisons","volume":"14","author":"Bishop","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"2019041122041387100_B29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2567.1997.00421.x","article-title":"Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction","volume":"90","author":"Carayanniotis","year":"1997","journal-title":"Immunology"},{"key":"2019041122041387100_B30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/thy.1996.6.267","article-title":"Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice","volume":"6","author":"Resetkova","year":"1996","journal-title":"Thyroid"},{"key":"2019041122041387100_B31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/thy.2006.16.427","article-title":"Blockade of costimulation between T cells and antigen-presenting cells: an approach to suppress murine Graves' disease induced using thyrotropin receptor-expressing adenovirus","volume":"16","author":"Chen","year":"2006","journal-title":"Thyroid"},{"issue":"10","key":"2019041122041387100_B32","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.4049\/jimmunol.153.10.4357","article-title":"Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B","volume":"153","author":"Berberich","year":"1994","journal-title":"J Immunol"},{"issue":"4","key":"2019041122041387100_B33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.18388\/abp.2008_3023","article-title":"The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment","volume":"55","author":"Kury\u0142owicz","year":"2008","journal-title":"Acta Biochim Pol"},{"issue":"7","key":"2019041122041387100_B34","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1210\/er.2009-0013","article-title":"Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases","volume":"30","author":"Beck","year":"2009","journal-title":"Endocr Rev"},{"issue":"48","key":"2019041122041387100_B35","doi-asserted-by":"crossref","first-page":"50050","DOI":"10.1074\/jbc.M407309200","article-title":"Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain","volume":"279","author":"Garside","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"2019041122041387100_B36","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/MCB.15.2.943","article-title":"Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors","volume":"15","author":"Scheinman","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2019041122041387100_B37","first-page":"10:e0145095.","article-title":"Protumoral TSP50 regulates macrophage activities and polarization via production of TNF-alpha and IL-1beta, and activation of the NF-kappaB signaling pathway","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"2019041122041387100_B38","first-page":"4:e7305.","article-title":"Basal cancer cell survival involves JNK2 suppression of a novel JNK1\/c-jun\/Bcl-3 apoptotic network","author":"Ahmed","year":"2009","journal-title":"PLoS ONE"},{"key":"2019041122041387100_B39","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1172\/JCI80467","article-title":"Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease","volume":"125","author":"Chen","year":"2015","journal-title":"J Clin Invest"},{"issue":"10","key":"2019041122041387100_B40","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1089\/105072503322511319","article-title":"A C\/T polymorphism in the 5\u2032-untranslated region of the CD40 gene is associated with Graves' disease in Koreans","volume":"13","author":"Kim","year":"2003","journal-title":"Thyroid"},{"issue":"5","key":"2019041122041387100_B41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/thy.2006.16.443","article-title":"Association of a C\/T single-nucleotide polymorphism in the 5\u2032 untranslated region of the CD40 gene with Graves' disease in Japanese","volume":"16","author":"Ban","year":"2006","journal-title":"Thyroid"},{"issue":"10","key":"2019041122041387100_B42","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/thy.2005.15.1119","article-title":"Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease","volume":"15","author":"Kurylowicz","year":"2005","journal-title":"Thyroid"},{"issue":"4","key":"2019041122041387100_B43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1507\/endocrj.52.471","article-title":"A C\/T polymorphism in the 5\u2032 untranslated region of the CD40 gene is associated with later onset of Graves\u2019 disease in Japanese","volume":"52","author":"Mukai","year":"2005","journal-title":"Endocr J"},{"issue":"5","key":"2019041122041387100_B44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1530\/EJE-08-0410","article-title":"Association of CD40 and thyroglobulin genes with later-onset Graves' disease in Taiwanese patients","volume":"159","author":"Hsiao","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2019041122041387100_B45","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1210\/en.2004-1617","article-title":"A Graves\u2019 disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology","volume":"146","author":"Jacobson","year":"2005","journal-title":"Endocrinology"},{"issue":"3","key":"2019041122041387100_B46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1172\/JCI118855","article-title":"Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes","volume":"98","author":"Koshy","year":"1996","journal-title":"J Clin Invest"},{"issue":"1","key":"2019041122041387100_B47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/cr.2010.161","article-title":"A single NF\u03baB system for both canonical and non-canonical signaling","volume":"21","author":"Shih","year":"2011","journal-title":"Cell Res"},{"issue":"18","key":"2019041122041387100_B48","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev"},{"key":"2019041122041387100_B49","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fimmu.2013.00376","article-title":"CD40-mediated zctivation of the NF-\u03baB2 pathway","volume":"4","author":"Hostager","year":"2013","journal-title":"Front Immunol"},{"issue":"4","key":"2019041122041387100_B50","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2567.2006.02329.x","article-title":"Distinct regulation of CD40-mediated interleukin-6 and interleukin-12 productions via mitogen-activated protein kinase and nuclear factor kappaB-inducing kinase in mature dendritic cells","volume":"117","author":"Yanagawa","year":"2006","journal-title":"Immunology"},{"issue":"5","key":"2019041122041387100_B51","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.4049\/jimmunol.162.5.2804","article-title":"Requirement for nuclear factor-kappaB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes","volume":"162","author":"Hsing","year":"1999","journal-title":"J Immunol"},{"issue":"10","key":"2019041122041387100_B52","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.4049\/jimmunol.159.10.4898","article-title":"Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes","volume":"159","author":"Hsing","year":"1997","journal-title":"J Immunol"},{"issue":"6","key":"2019041122041387100_B53","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-kappaB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol"},{"issue":"3","key":"2019041122041387100_B54","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4049\/jimmunol.163.3.1577","article-title":"Essential role of T cell NF-kappa B activation in collagen-induced arthritis","volume":"163","author":"Seetharaman","year":"1999","journal-title":"J Immunol"},{"issue":"4","key":"2019041122041387100_B55","first-page":"26","article-title":"Targeting NF-\u03ba\u0392 and TNF-\u03b1 activation by electroacupuncture to suppress collagen-induced rheumatoid arthritis in model rats","volume":"21","author":"Li","year":"2015","journal-title":"Altern Ther Health Med"},{"issue":"1","key":"2019041122041387100_B56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12020-015-0552-7","article-title":"Increased chemokine (C-C motif) ligand 21 expression and its correlation with osteopontin in Graves\u2019 disease","volume":"50","author":"Qi","year":"2015","journal-title":"Endocrine"},{"issue":"9","key":"2019041122041387100_B57","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/thy.2015.0029","article-title":"B cell activating factor (BAFF) and BAFF receptor expression in autoimmune and nonautoimmune thyroid diseases","volume":"25","author":"Campi","year":"2015","journal-title":"Thyroid"},{"issue":"12","key":"2019041122041387100_B58","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1167\/iovs.12-9861","article-title":"Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-\u03baB","volume":"53","author":"Gillespie","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"2019041122041387100_B59","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0961203313496302","article-title":"Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus","volume":"22","author":"Vincent","year":"2013","journal-title":"Lupus"},{"key":"2019041122041387100_B60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000082106","article-title":"The BAFF\/APRIL system: an important player in systemic rheumatic diseases","volume":"8","author":"Mackay","year":"2005","journal-title":"Curr Dir Autoimmun"},{"issue":"1","key":"2019041122041387100_B61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sj\u00f6gren\u2019s syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J Clin Invest"},{"issue":"1","key":"2019041122041387100_B62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/annrheumdis-2011-201282","article-title":"Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)","volume":"72","author":"Dougados","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"2019041122041387100_B63","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/annrheumdis-2013-204760","article-title":"Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study","volume":"73","author":"Genovese","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2019041122041387100_B64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1586\/1744666X.2015.996550","article-title":"Belimumab for the treatment of systemic lupus erythematosus","volume":"11","author":"Jordan","year":"2015","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/158\/2\/410\/10012432\/en.2016-1609.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T02:46:18Z","timestamp":1692585978000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/158\/2\/410\/2965951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,8]]},"references-count":64,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,12,8]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2016-1609","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2,1]]},"published":{"date-parts":[[2016,12,8]]}}}